.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Dr. Irene Pamler

Regensburg/ DE

Universitätsklinikum Regensburg

Speaker

21/09/2023
16:40 – 16:42 2 Min. 0 Min.
ePoster
PS-4-6
Successful erythrocytapheresis in patients with hereditary hemochromatosis
Hemotherapy

Further involvements

21/09/2023
16:40 – 16:42 2 Min. 0 Min.
ePoster
PS-4-6
Successful erythrocytapheresis in patients with hereditary hemochromatosis
Hemotherapy
21/09/2023
16:57 – 17:00 2 Min. 1 Min.
ePoster
PS-2-10
More than 6 years experience with the collection of granulocytes using modified fluid gelatin 4%
Blood Components
21/09/2023
17:00 – 17:05 3 Min. 2 Min.
ePoster
PS-3-7
Immune adsorption as an individual experimental therapy in two patients with multiple autoantibodies and post-COVID-19 syndrome
COVID-19
21/09/2023
17:14 – 17:16 2 Min. 0 Min.
ePoster
PS-4-23
Titer progression of two blood group alloantibodies under massive antibody-reducing chemo- and apheresis therapy
Immunohematology